Back to Search

RICHARD SYLVESTER, PHD, MP, MPAP

PHD, MP, MPAP

Prescribing (Medical) Psychologist

NPI: 1164771168IndividualAccepts Medicare

Specialties, Licenses & Credentials

Prescribing (Medical) PsychologistPrimary

Psychologist — Prescribing (Medical)

Code: 103TP0016X

330644(LA)349435(LA)

CMS Specialties

PrimaryCLINICAL PSYCHOLOGIST

Education

OTHER

Class of 2014

Research & Publications (20)

A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trials.
PMID 19502050·Eur J Cancer·2009
8-other
Re: Can early single dose instillation of epirubicin improve bacillus calmette-guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study: T. Cai, G. Nesi, G. Tinacci, E. Zini, N. Mondaini, v. Boddi, s. Mazzoli and R. Bartoletti J Urol 2008; 180: 110-115.
PMID 19010500·J Urol·2009
8-other
[EAU guidelines on non-muscle-carcinoma of the bladder].
PMID 19579886·Actas Urol Esp·2009
6-review
A hospice-based advanced pharmacy experience.
PMID 19564987·Am J Pharm Educ·2009
8-other
An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed?
PMID 19375216·Eur Urol·2009
8-other
Analysis of Rex1 (zfp42) function in embryonic stem cell differentiation.
PMID 19618472·Dev Dyn·2009
7-preclinical
Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.
PMID 19576682·Eur Urol·2009
6-review
Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881.
PMID 18848382·Eur Urol·2009
3-trial
An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.
PMID 19409692·Eur Urol·2009
4-observational
Bacillus Calmette-Guérin versus mitomycin C for the treatment of intermediate-risk non-muscle-invasive bladder cancer: the debate continues.
PMID 19427110·Eur Urol·2009
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
622 RIVERSIDE DR
MONROE, LA 71201

Locations (2)

Practice Location

622 RIVERSIDE DR, MONROE, LA
(318) 398-0945

Practice Location

1401 N 7TH ST STE B, WEST MONROE, LA
(318) 503-8300

Quick Facts

NPI
1164771168
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
12
Publications
20

Are you this provider?

Claim Your Profile